Peritoneal bladder fistula following radiotherapy for cervical cancer: A case report

Introduction

Radiation cystitis frequently occurs following radiotherapy treatment for cervical, colorectal and prostate cancer, in addition to other pelvic tumors, with an incidence rate of ≤5% of all patients that undergo radiotherapy (1). Previous studies have reported that acute radiation cystitis, which typically develops 2–4 weeks after radiotherapy with a severity of <II [Radiation Therapy Oncology Group staging system (2)], occurs in 21–25% of all patients that undergo radiotherapy, while chronic radiation cystitis has an incidence rate of 1% (3). The occurrence and severity of radiation cystitis has gradually decreased due to technical advances in the field of radiotherapy (4). To the best of our knowledge, the occurrence of a peritoneal bladder fistula as a result of radiation cystitis following radiotherapy for cervical cancer has not been reported in the literature. The present study reports a case of a peritoneal bladder fistula, which occurred 20 years after the administration of radiotherapy for cervical cancer, and discusses the possible causes and potential treatments for this condition.

Case report

A 50-year-old woman, who was previously diagnosed with cervical cancer and treated with radiotherapy 20 years ago in June 1994, was admitted to the First Affiliated Hospital of Xi'an Jiatong University (Xi'an, China). No recurrence or metastasis was observed during the periodic examinations that followed the diagnosis. The patient began experiencing intermittent increased urination frequency, urination urgency and hematuria 10 years ago, and was subsequently treated with Chinese medicine for 1 year, which alleviated the symptoms. However, 3 years ago, the patient experienced sudden abdominal pain and bowel difficulties following urination. B-ultrasound examination at The People's Hospital of Tongchuan (Tongchuan, China) detected the presence of abdominal pelvic fluid. Following antibiotic (levofloxacin for 5 days) and ascites extraction treatment, symptoms were relieved without any recurrence. Five days prior to admission to the First Affiliated Hospital of Xi'an Jiatong University on June 25, 2014, the patient experienced difficulty urinating, abdominal pain and bloating, but did not experience frequent urination, hematuria or fever. B-ultrasound examination indicated a rough bladder wall and a large pelvic effusion. Laboratory examinations performed 5 days prior to admission revealed mild urinary occult blood, severe urinary protein, blood urea nitrogen (BUN) levels of 12.34 mmol/l and creatinine (CREA) levels of 268 umol/l. Further examinations revealed that blood pressure, heart rate, temperature and chest X-ray were all normal, in addition to abdominal tension, no tenderness or rebound tenderness, no liver or spleen palpation, no percussion pain in the kidney area, positive shifting dullness and normal bowel sounds. Gynecological examination was normal. The diagnosis at admission was suspected as i) ascites of unknown reason and ii) cervical cancer. Routine blood and liver function tests following admission were normal, and tumor marker levels, including cancer antigen (CA)125, CA153, CA199, carcinoembryonic antigen and squamous cell carcinoma antigen, were also normal. Chest and abdominal computed tomography and pelvic magnetic resonance imaging examination excluded tumor recurrence and metastasis. BUN and CREA levels in ascites, blood and urine were tested following hospital admission and are presented in Table I. Routine biochemical tests were performed for ascites and urine, which indicated that the ascitic fluid was transudate (Tables II and III). Pathological examination of ascites revealed the presence of mesothelial cells and lymphocytes; however, no malignant tumor cells were identified. Therefore, a peritoneal bladder fistula was suspected and urine ascites were subsequently obtained. Cystoscopic examination revealed pale and thick bladder mucosa, vascular thickening and the formation of a visible fistula on the bladder wall measuring 1×1 cm in diameter (Fig. 1). The preliminary diagnosis was the presence of a peritoneal bladder fistula with radiation cystitis. Following catheterization and ascites extraction, the symptoms were relieved and the blood BUN and CREA levels had reduced to 6.4 mmol/l and 166 umol/l, respectively. Cytoscopic examination 1 month later revealed no evidence of the fistula (Fig. 2). The final diagnosis was confirmed as a peritoneal bladder fistula as a result of radiotherapy for cervical cancer. The patient was followed up everyday 3 months for a year and a half, and is currently alive and well.

Figure 1. Cystoscopic examination of the bladder. Examination revealed pale and thick bladder mucosa, vascular texture thickening and a fistula (diameter, 1×1 cm) on the bladder wall.

Figure 2. Cystoscopic examination of the bladder 1 month later. No evidence of the fistula is visible.

Table I. Patient BUN and CREA levels in the blood, urine and ascites following hospital admission.

Table I.

Patient BUN and CREA levels in the blood, urine and ascites following hospital admission.

	Blood (normal range)	Urine	Ascites
BUN, mmol/l	18.53 (2.60–7.50)	72.24	31.05
CREA, mmol/l	288 (41.00–73.00)	12124	1371

[i] BUN, blood urea nitrogen; CREA, creatinine.

Table II. Examination results for ascites and urine.

Table II.

Examination results for ascites and urine.

Parameters	Ascites	Urine
Color	Light yellow	Light yellow
Transparency	Transparent	Transparent
Clot	No clot	No clot
Rivalta test	Negative	Negative
Total cells	72×106/l	21×106/l
White blood cells	38×106/l	11×106/l

Table III. Biochemical test results for ascites and urine.

Table III.

Biochemical test results for ascites and urine.

Biochemical parameters	Ascites	Urine
Total protein, g/l	7.53 (<40)	3.02 (60–80)
Glucose, mmol/l	9.15 (3.60–6.10)	3.14 (3.60–6.10)
Lactate dehydrogenase, U/l	40.6 (109–245)	32.2 (109–245)
Chlorine, mmol/l	96.9 (96–108)	35.6 (96–108)
Adenosine deaminase, U/l	0.7 (<20)	0 (<20)

Discussion

Radiation cystitis typically affects the trigone of the urinary bladder and the surrounding tissues (5). Generally, the tolerated radiation dose of the bladder is considered to be 60 Gy; therefore, radiation cystitis may occur if the dose exceeds this. A previous study reported that radiation cystitis develops after receiving a dose that is 10% higher than the regular dose (60 Gy) (6,7). The primary pathological symptoms of radiation cystitis include ulcers accompanied by bleeding, inflammatory cell infiltration and epithelial cell atrophy or hyperplasia (8). Biopsies of bladder tissues exhibiting radiation cystitis usually demonstrate shedding of bladder transitional epithelial cells and cellulose inflammatory exudates. Necrotic tissue below the epithelium is also often observed, in addition to a thin layer of granulation containing numerous thin-walled blood vessels and fibrous tissue hyperplasia with hyaline degeneration, which involves the muscular layer and the outer membrane (9). Shedding of bladder epithelial mucosal cells results in the loss of epithelial protection and the permeability barrier (9). Consequently, extensive amounts of water and urea permeate into the smooth muscle layer of the bladder, resulting in nerve hyperexcitability, detrusor muscle dysfunction and sudden, painless hematuria associated with bladder irritation (9).

Radiation cystitis may be divided into three types according to the time of occurrence and severity: Acute radiation cystitis, chronic radiation cystitis and radiation bladder fistula (10). Acute radiation cystitis usually occurs within 6 months of radiotherapy and is characterized by gross or microscopic hematuria associated with urinary tract irritation symptoms, including increased urinary frequency and urgency. These symptoms may be relieved when radiotherapy is terminated or following relevant treatment (11). Chronic radiation cystitis accounts for 80% of cases of radiation cystitis and usually occurs 2–4 years after radiotherapy due to the delayed healing of acute radiation cystitis or late stage radiation injuries (11). Radiation bladder fistulas present further development of chronic radiation cystitis. Obstetric fistulas are the most common, while peritoneal bladder fistulas are rare (12). Radiation bladder fistulas are associated with the distribution of the radiation dose (5). The trigone of the urinary bladder receives the highest radiation doses during pelvic radiotherapy; therefore, radiation cystitis and obstetric fistulas usually occur in this region (5). To the best of our knowledge, no cases of peritoneal bladder fistulas as a result of radiotherapy have been reported previously. The primary causes of bladder fistulas are trauma, surgery, tumors and radiotherapy, and surgery is the standard treatment option (13).

In the present study, a peritoneal bladder fistula occurred as a result of radiotherapy, bladder cystitis and excessive urinary holding. Long-term radiation bladder cystitis leads to fibrosis of bladder mucosa and a reduction in bladder wall tension. Therefore, sudden increases in bladder capacity and wall tension may result in rupture. Notably, the rupture observed in the patient of the present study was not located in the trigone of the urinary bladder and was instead located in the back wall of the bladder, thus resulting in the development of a peritoneal bladder fistula and leakage of urine into the peritoneal cavity. In the early stages of the disease, catheterization and other symptomatic treatments, including hemostasis, anti-inflammatory and sodium hyaluronate treatment, may heal the fistula via bladder self-repair (13). However, in patients with delayed healing, long-term stimulation of the peritoneum by urine may result in abdominal pain and infection, and life-threatening infectious peritonitis. The present case demonstrates that urinary holding must be avoided in patients with a history of pelvic radiotherapy as it may lead to the formation of a bladder fistula. In addition, patients with sudden urinary difficulties and ascites following radiotherapy must be monitored for the development of peritoneal bladder fistulas. Cystoscopy is the preferred method of examination and diagnosis, and early detection and treatment may significantly improve the patient prognosis.

In conclusion, the occurrence of peritoneal bladder fistulas following radiation therapy is rare and may easily be misdiagnosed as peritoneal metastasis with ascites. If a patient that has undergone abdominal or pelvic radiotherapy and been diagnosed with chronic radiation cystitis experiences sudden abdominal pain, severe unexplained ascites and dysuria, the possibility of a peritoneal bladder fistula should be considered. Early cystoscopic examination and timely treatment may significantly improve the prognosis.

References